Epidermodysplasia verruciformis (EV) is a rare genetic disease characterized by abnormal susceptibility to infection with EV-related human papillomavirus (HPV), now known as the β-papillomavirus (β-PV). Clinically specific β-PV-type-associated EV, especially HPV-5 and -8, shows a high rate of progression to squamous cell carcinoma (SCC). In this report, we describe a 39-year-old Korean man with HPV-22b-associated EV who developed a rapidly progressing SCC. The patient presented with a huge destructive mass on the nose. Histopathological evaluation of the mass was compatible with well-differentiated SCC. HPV typing results from both EV and SCC specimens demonstrated HPV-22b which has not been considered to be associated with SCC in EV patients so far. The patient underwent surgical excision and postoperative radiotherapy for locoregional control. This is the first report presenting the association of an SCC arising from previous EV with HPV-22b infection only.

Rajagopalan K, Bahru J, Loo DS, Tay CH, Chin KN, Tan KK: Familial epidermodysplasia verruciformis of Lewandowsky and Lutz. Arch Dermatol 1972;105:73–78.
Orth G: Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 2006;18:362–374.
de Oliveira WR, Festa Neto C, Rady PL, Tyring SK: Clinical aspects of epidermodysplasia verruciformis. J Eur Acad Dermatol Venereol 2003;17:394–398.
Pfister H: Chapter 8: Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003;31:52–56.
Feltkamp MC, de Koning MN, Bavinck JN, Ter Schegget J: Betapapillomaviruses: innocent bystanders or causes of skin cancer. J Clin Virol 2008;43:353–360.
Asgari MM, Kiviat NB, Critchlow CW, Stern JE, Argenyi ZB, Raugi GJ, Berg D, Odland PB, Hawes SE, de Villiers EM: Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. J Invest Dermatol 2008;128:1409–1417.
Forslund O, Iftner T, Andersson K, Lindelof B, Hradil E, Nordin P, Stenquist B, Kirnbauer R, Dillner J, de Villiers EM: Cutaneous human papillomaviruses found in sun-exposed skin: beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis 2007;196:876–883.
Hazard K, Eliasson L, Dillner J, Forslund O: Subtype hpv38b[fa125] demonstrates heterogeneity of human papillomavirus type 38. Int J Cancer 2006;119:1073–1077.
Lindh M, Gorander S, Andersson E, Horal P, Mattsby-Balzer I, Ryd W: Real-time Taqman PCR targeting 14 human papillomavirus types. J Clin Virol 2007;40:321–324.
Cooper KD, Androphy EJ, Lowy D, Katz SI: Antigen presentation and T-cell activation in epidermodysplasia verruciformis. J Invest Dermatol 1990;94:769–776.
Lazarczyk M, Pons C, Mendoza JA, Cassonnet P, Jacob Y, Favre M: Regulation of cellular zinc balance as a potential mechanism of ever-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med 2008;205:35–42.
Jablonska S, Dabrowski J, Jakubowicz K: Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res 1972;32:583–589.
Berkhout RJ, Bouwes Bavinck JN, ter Schegget J: Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000;38:2087–2096.
Weissenborn SJ, Nindl I, Purdie K, Harwood C, Proby C, Breuer J, Majewski S, Pfister H, Wieland U: Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol 2005;125:93–97.
Jackson S, Harwood C, Thomas M, Banks L, Storey A: Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 2000;14:3065–3073.
Bouwes Bavinck JN, Plasmeijer EI, Feltkamp MC: Beta-papillomavirus infection and skin cancer. J Invest Dermatol 2008;128:1355–1358.
Bogdan I, Scharer L, Rudlinger R, Hafner J: Epidermodysplasia verruciformis in two brothers developing aggressive squamous cell carcinoma. Dermatol Surg 2007;33:1525–1528.
Gul U, Kilic A, Gonul M, Cakmak SK, Bayis SS: Clinical aspects of epidermodysplasia verruciformis and review of the literature. Int J Dermatol 2007;46:1069–1072.
St-Pierre S, Baker SR: Squamous cell carcinoma of the maxillary sinus: analysis of 66 cases. Head Neck Surg 1983;5:508–513.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.